The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
about
MDMA for the treatment of mood disorder: all talk no substance?Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporterA human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPsNeurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancyReinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeysA current view of serotonin transportersInsights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDATMechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.mCPP: an undesired addition to the ecstasy marketComparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methyloneThe mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brainLabelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic systemIn vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMADuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyVerbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot StudyNon-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma CellsCysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformationSerotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy useRaves: a review of the culture, the drugs and the prevention of harm.Developmental consequences of fetal exposure to drugs: what we know and what we still must learnNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineSerotonin: a regulator of neuronal morphology and circuitrySerotonergic dystrophy induced by excess serotonin.In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Modified structure of the human serotonin transporter promoter.Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in miceStatistical prediction of protein chemical interactions based on chemical structure and mass spectrometry data.Compensatory responses in the aging hippocampal serotonergic system following neurodegenerative injury with 5,7-dihydroxytryptamine.Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures.Conformational flexibility of transmembrane helix VII of the human serotonin transporter impacts ion dependence and transport.p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.Flux coupling in the human serotonin transporterRegulation of monoamine transporters: Role of transporter phosphorylation.Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
P2860
Q21558551-08CEFC1D-3DBD-46C0-94AC-2F0EDB4EB740Q24298107-990A2D3E-CAF3-4DBA-B6D1-E8C1D78E5F2FQ24314400-8733BFBB-0058-443C-BF04-B760BB7C1360Q24321541-AEED7ED1-4900-44AB-8340-6E6D357BD965Q24612266-48876F00-4510-4940-B2A4-39F62EDB9ADEQ24629918-B692370E-554A-4712-AFEF-0631B9ACBB3FQ26740309-1625DBAF-D182-4855-A4FA-79BB01DDF640Q26781554-B0395D73-C0E2-4719-B896-393B8C80768BQ27333086-1A22E46A-0674-44B8-83D2-2130AF7C1AC9Q28238953-38C5EC8B-E60B-4AE5-AE41-09E71EA2E96FQ28264655-A4F77281-28FE-440B-BA4B-313180915784Q28346708-54408D4B-75C3-4DAE-BC38-3BB6CA588970Q28361167-B18A6094-C4C9-4AB6-BAEE-21D6AA1B8FA5Q28365378-E1CF9318-0D1E-403E-8D48-3BF861DD5B95Q28483370-D8DD3E2F-7EF2-48A7-B593-A7861B6B6993Q28486090-391C73B4-296A-48D0-B452-3088B5918CBAQ28512294-C12DC95E-260E-4148-BF1E-1FA6189D72BAQ28546929-B73BBEA3-F12C-45AD-8FA5-B28CBF0D869DQ28553620-7694640C-113B-472E-8E15-F9DDD9429C56Q28566579-7BAF532C-470C-4023-B788-435048265C40Q29473848-73883747-E9DD-4C59-973C-4ACFF805C1D3Q30327023-6C80C5AF-8DD4-40C2-BF1F-2B75CAEBBD9BQ30395013-F0ED86DA-E06A-46E8-AD50-560A569A88C6Q30417935-0CE9FB1A-E67F-47C5-8CC9-119BD68944F3Q30430944-E8B310DD-43D1-44E9-9034-2BBA374F934FQ30431654-0258FF81-E7D5-4F87-8D6B-088236A0EE72Q30535782-7B6E00D5-557B-430D-8F80-87B693DA9F0BQ30838988-71C81CC0-D812-4ACD-A1A7-FF3F9791C7E0Q30946517-8999362D-9B61-447C-938C-995539FE412BQ31113004-0AE55AE9-5A6E-44F3-857E-5BCFC1A945FEQ31949032-29BAF6A5-32C0-455A-BE47-E8C608E47B3FQ33799683-00471B5C-BDB6-4F2B-B7AD-311B5DB16254Q34030711-DAB86612-18C0-4F24-8198-53567042C037Q34042872-1C0FC19B-8E49-4188-80F8-AD8C28859744Q34126464-55A1D6CC-95E1-4A88-B293-AE20851D4498Q34152289-2B4EB8A7-BEA8-4A18-BF69-D1CD141B9C9DQ34179403-AE313934-9915-48D0-9580-E1D3249A11CBQ34540543-4CF8D6EA-0C1C-49E5-B2AF-DC80F18AD2B0Q34767737-6AB58EE8-035D-46C3-B2AF-758AEBBAFFC2Q34943864-AD78ED8E-313D-4FD5-A89B-031385574BA0
P2860
The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The molecular mechanism of "ec ...... DMA-induced serotonin release.
@en
type
label
The molecular mechanism of "ec ...... DMA-induced serotonin release.
@en
prefLabel
The molecular mechanism of "ec ...... DMA-induced serotonin release.
@en
P2860
P356
P1476
The molecular mechanism of "ec ...... DMA-induced serotonin release.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.5.1817
P407
P577
1992-03-01T00:00:00Z